Global Gene has partnered with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), Department of Radiation Oncology, to research into cancers in South Asian and Indian populations.
The partnership with OSUCCC-James will help support the company’s aim of focusing on personalised healthcare data at a global level.
Go deeper with GlobalData
Under the collaboration, the partners will molecularly profile tumours using the latest and advanced technology deployed in the laboratory of OSUCCC-James Department of Radiation Oncology chairman Dr Arnab Chakravarti.
Chakravarti said: “To help fight cancer, one has to build a representative and unique perspective that leads to novel insights.
“India and South East Asia have different manifestations of cancer compared to cancers that are considered rare in the West. We aim to study why.”
As part of the deal, Global Gene will provide access to longitudinal, genomics data, insights and analytics for unexplored patient populations in South Asia.
Global Gene chairman and chief executive officer Sumit Jamuar said: “Using a high-throughput approach to understand the drivers for a variety of rare and common cancers will allow us to truly develop insights that will lead to personalised medicine for patients.
“By working with under-represented populations, both organisations can fill in key gaps needed for discovery with global applications, while simultaneously helping people in South Asian and Indian populations.”
